PTPA and cancer: Studies using PP2A as a pharmacologic target in cancer therapy gave contradictory results35, in which PP2A inhibition using natural compounds, such as okadaic acid and microcystins, have been shown to be both pro-proliferative and pro-apoptotic in cancer cells.